Abstract. A mAb (lE5) that binds the COOH-terminal region of the 0 subunit of chicken CapZ inhibits the ability of CapZ to bind the barbed ends of actin filaments and nucleate actin polymerization . CapZ prepared as fusion proteins in bacteria or nonfusion proteins by in vitro translation has activity similar to that of CapZ purified from muscle . Deletion of the 000H-terminus of the 0 subunit of CapZ leads to a loss of CapZ's ability to bind the barbed ends of actin filaments . A peptide corresponding to the COOH-terminal region C HICKEN CapZ is an actin-binding protein that binds the barbed ends of actin filaments in vitro (9) and nucleates actin polymerization (5) . CapZ is a member of the "capping protein family, which are heterodimers with subunits of 31-36 kD (a) and 28-32 kD (0) (19). Members ofthis family have been cloned from chicken (6, 10, 12), Dictyostelium (15), Xenopus (2), and S. cerevfsiae (1), and protein has been purified from a wide variety of eukaryotes (19) . Capping protein purified from chicken muscle (18) has been called CapZ because it localizes to the Z-line (9), suggesting that it binds the barbed ends of the actin filaments in the sarcomere. In chicken, the genes encoding muscle CapZ are also expressed in nonmuscle tissues (6, 12) , and capping protein has been localized to structures that contain actin filaments in epithelial cells (Schafer, D. A., M. B. Heintzelman, M. S. Mooseker, and J. A. Cooper; manuscript submitted for publication). Deletion of the gene for the ß subunit of capping protein in yeast leads to an alteration in the actin cytoskeleton (1) .
DNA restriction and modifying enzymes were from Promega Biotec (Madison, WI) . Protein concentration was determined by the method of Bradford with BSA as the standard (4) . Recombinant DNA manipulations were performed as described (21) .
Bacterial Fusion Protein Constructs
A cDNA for the complete 0 subunit of chicken skeletal muscle CapZ (277 amino acids) was obtained as described (6) and in this study is called pBS-0 . This cDNA is cloned into the EcoRl site of the pBlueScript SK(-) (pBS, Stratagene, La Jolla, CA) cloning vector, in frame with 0-galactosidase . pBS-0(1-265) was constructed by digesting pBS-0(1-277) with Hincll (this restriction enzyme recognition site is at nucleotide 794 of the 0 subunit cDNA [6] ) to excise the 3' region of the coding sequence, the 3' untranslated sequence, and a portion of the polylinker. The large fragment was isolated and religated . An unintentional loss of a base introduced a stop codon after V265 . pBS-0(1-267)/0-gal was constructed identically without loss of a base, resulting in a 3' fusion protein with vector sequence. This construction restored the normal residues L266, T267, and R269 but changed Q26s to S and added additional residues from the vector as shown in Fig . 1 .
For expression, the CapZ 0 cDNAs were cloned into the pGex vector in which CapZ 0 is preceded by glutathione-S-transferase (GST)' (23) .
pGex-0(1-277) was constructed using the polymerase chain reaction (PCR), the forward primer 1, the reverse primer 2, and 10 ng of pBS-0(1-277) template DNA . The sequence of oligonucleotide primers is given in Table 1 . The PCR product was digested with BamHI and EcoRI, gel purified, and ligated into similarly digested pGex-1 to produce pGex-0(1-277) . The BamHl-EcoR1 insert of pGex-0(1-277) was also cloned into similarly digested pBS vector and designated pBS[pGex-0(1-277)1 . pGex-0(1-265) was constructed by digesting pBS-0(1-265) with KpnI (nucleotide 552 of the 0 subunit cDNA) . The 3' fragment corresponding to the truncated coding sequence of pBS-0(1-265) was purified and ligated into Kpnl-digested pBS[pGex-0(1-277)1, which had been gel purified to remove the 3' fragment ofthe complete coding region, to produce pBS[pGex-0(1-265)] . pBS[pGex-0(1-265)1 was digested with XhoI, filled with T4 DNA polymerase, digested with BamHI, gel purified, and ligated into BamHI and Smal digested pGex-1 to produce pGex-01 . pGrex-0(1-266) was con- 1 . Abbreviations used in this paper: GST, glutathione-S-transferase ; PCR, polymerase chain reaction . structed by digesting pGex-0(1-277) with BarnHI and HincH and ligating the released insert into pGex-1 digested with BamHI and Smal . This construct includes five vector-derived codons after L266 of the 0 subunit, followed by a stop codon . pGex-ß(2l3-277) was constructed by digesting pBS-0(1-277) with SspI (nucleotide 636 of the 0 subunit cDNA) and EcoRI, and purifying and ligating this fragment, which encodes the COOH-terminal 65 amino acids of the 0 subunit, into Smal-and EcoRl-digested pGex3x.
pGex-0(1-212) was constructed by digesting pGex-0(1-277) with BamHI and SspI, and ligating the fragment encoding the NH2-terminal 212 amino acids into BamHI-and SmaI-digested pGex-1 . This construct includes four vector-derived codons following N 212 of the 0 subunit, followed by a stop codon . pGex-ß(2S3-277) was constructed using the PCR with the forward primer 3, the reverse primer 2, and 10 ng of pBS-0(1-277) template. The reaction product was digested with BamHI and EcoRI, gel-purified, and ligated into pGex-1 digested with BamHI and EcoRL pGex-0(264-277) was constructed using the PCR with the forward primer 4, the reverse primer 2, and 10 ng of pBS-0(1-277) template DNA . The reaction products were digested with Bg1II and EcoRl, gel purified, and ligated into BamHI-and EcoRI-digested pGex3x .
For expression of the a subunit of CapZ, pGex-a2 was constructed. Al 1916, a full-length CapZ a2 subunit cDNA in pBS with an NcoI site engineered at the initiating ATG, was digested with Ncol and EcoRV to release the entire coding sequence . The insert was gel purified and ligated into BamHI-and Smal-digested pGex-1 with the annealed NcoI-BamHI adaptor produced by oligonucleotides 5 and 6.
The 5' and 3'vector-insert boundaries were verified with oligonucleotideprimed double-strand dideoxy sequencing using modified T7 polymerase (United States, Biochemical Corp., Cleveland, OH) and purified plasmid DNA. To check for PCR-introduced error, the coding sequences of pGex-0(1-277) and pGex-ß(2S3-277) were sequenced .
XI-1 Blue bacteria were used for all recombinant DNA and subsequent fusion protein procedures and were always grown at 37°. All bacterial constructs were assayed for production of a polypeptide of the expected size by protein induction (23), SDS-acrylamide gel electrophoresis of total cellular proteins (17) , and Coomassie staining of the gel or immunoblotting (25) . Immunoblots were blocked in 1% BSA and 5% fish gelatin in TTBS (20 mM Tris/HCl, pH 7.5, 0.3 M NaCl, 0.01% NaN 3 , 0.05% Tween 20) for 30 min . Primary antibodies were (a) a goat polyclonal antiserum prepared against purified chicken CapZ and affinity purified against chicken CapZ or GSTa2 and GST$ immobilized on nitrocellulose (Schafer, D. A ., M . B. Heintzelman, M . S. Mooseker, and J. A . Cooper, manuscript submitted for publication) ; (b) preimmune immunoglobulins from the same animal ; or (c) hybridoma ascites of mouse mAbs that recognize the a subunit (1Bll) and the 0 subunit (1E5) of chicken CapZ (Fig . 2) . Purified Igs were used at 1.5 Ag/ml in blocking solution, and ascites was diluted 1 :10,000 in blocking solution. Secondary antibodies were alkaline phosphataseconjugated affinity-isolated swine anti-(goat Igs) or goat anti-(mouse Igs) (Tago, Burlingame, CA) . Washes were in TTBS ; development was as described (13) .
Recombinant Fusion Protein Preparation
Overnight cultures of the appropriate bacterial strains were diluted 1 :10 into 800 nil of fresh LB media, grown with vigorous aeration for 2 h and induced with 0.1 mM isopropyl-O-D-thiogalactopyranoside for two additional h . Cultures were chilled on ice for 30 min and centrifuged at 4,500 g for 15 min at 4°C. All subsequent procedures were carried out at 4°C or on ice. Bacteria were resuspended in 32 ml MTPBS (150 mM NaCl, 16 mM Na2HP04, 4 mM NaH2PO4, pH 7.4) with 10 mM EDTA, 0.1 mM DTT, 0.1 mM PMSF, 0.1 mM benzamidine, 0.1 mM leupeptin, and 0.1 mM pepstatin A . Separate bacterial cultures expressing GSTCapZ a and GST CapZ 0 subunits were combined at this point. The suspension was sonicated to lyse the cells. Urea was added to 1 M and sarcosyl to 0.2% . The lysate was centrifuged at 32,000 g for 20 min. The supernatant was decanted, and, after addition of Triton X-100 to 1%, mixed with 15 ml glutathione agarose beads . The mixture was incubated for 1 h with rocking, poured into a column, and washed sequentially with 10 column volumes of MTPBS with 1% Triton X-100 and 10 column volumes of MTPBS. Recombinant protein was eluted with 20 mM glutathione, 50 mM Tris/HCI, 0.01% NaN3, pH 8.0, concentrated with a Centricon-30 (Amicon Corp ., Danvers, MA) and chromatographed on a Superose 6 HR gel filtration column (Pharmacia Fine Chemicals, Piscataway, NJ) in buffer B (50 mM KCI, 0.5 mM EDTA, 10 mM Tris/HCI, pH 8 .0, 1 mM 2-mercaptoethanol, 0.1 mM PMSF, 0.01% NaN 3) . The profile included an early and a late peak . The late peak coincided with the elution position of GSTCapZ a or GSTCapZ 0 alone . The early peak was active in a low-shear viscometry assay, and the late peak was not . The early peak was pooled and rechromatographed, eluting at the same early position . This material was used for activity assays and contains approximately equimolar amounts of GSTCapZ a and GSTCapZ 0 by SDS-PAGE (Fig . 3) . For purification of GSTa/GSTO(1-266), GSTa/GST 0(1-265), and GSTa/GST0(1-212) heterodimers, the early peak from the Superose 6 column was pooled and rechromatographed and used for activity assays . These preparations contain approximately equimolar amounts of each subunit by SDS-PAGE (Fig . 3) . For experiments using 000H-terminal fusion peptides GST0(253-277) and GST0(264-277) as well as GST alone, the pooled peak fractions from the glutathione agarose column were dialyzed into buffer B and used without further purification . The purity of these preparations is shown in Fig . 3 
Proteins
Actin and CapZ were prepared from chicken pectoralis muscle as described (7, 16) . Pyrene actin was prepared and used in fluorometric assays of actin polymerization as described (16) . Actin was dialyzed overnight versus Cat+ or Mgt+ -G-buffer (Ca2+ -G-buffer: 200 AM ATP, 2 mM Tris-HCI, pH 8.0, 100 AM DTT, 0.005% NaN3 , 200 AM CaC12 ; Mg t+-G-buffer : 100 AM ATP, 2 mM Tris-HCI, pH 8 .0, 100 AM DTT, 0.005% NaN3, 50 AM M9C12) and centrifuged at 100,000 g for 1 h before use .
Monoclonal Antibodies
Balb c/J mice were immunized with purified chicken CapZ . Spleen cells were fused with P3X63 Ag8 .653 myeloma cells by the Hybridoma Center of Washington University. Medium was screened by ELISA and positive wells were subcloned in soft agar. Hybridoma clones were grown as ascites . mAb from ascites and mouse IgG from normal serum were purified by affinity chromatography on protein A-Sepharose (14) and anion exchange chromatography (Mono Q ; Pharmacia Fine Chemicals) and dialyzed into PBS (0.137 M NaCl, 2 .6 mM KCI, 1 .5 mM KH2P04, 8 mM Na2HP04, 0.01% NaN3, pH 7.4) . mAbs 1B11 and IE5 are both IgGI by analysis with specific antibodies (data not shown) . 1B11 binds CapZ a and IE5 binds CapZ ß by inununoblot (Fig . 2 ) .
Assay of Capping Activity by Inhibition of Filament Depolymerization
Actin filaments for depolymerization experiments were prepared by polymerizing actin for 1 h at -30 AM in the presence of MKEI buffer (100 mM KCI, 2 mM MgC12, 1 mM EGTA, 20 mM imidazole/HCI, pH 7.0) . The actin was diluted to 5.0 AM, mixed, and incubated 1 h to allow equilibration of monomers and filaments.
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Antibodies. 12 Al of 600 nM CapZ in buffer B with 0.1 mg/ml BSA was added to 108 Al mAb at various concentrations in PBS with 0.1 mg/ml BSA in silanized microfuge tubes and incubated for 1 h . 100 Al of this CapZ/antibody solution was added to 2,350 Al Cal'-G-buffer in a fluorometer cuvette. 60 141 of 5 .0 AM, 70% pyrene-labeled actin filaments was vortexed for 10 s, and 50 Al was added to the cuvette . The cuvette was stirred for 15 s . The capping activity of each sample was calculated by dividing the fluorescence at 150 s by the initial fluorescence, and subtracting the fluorescence at 150 s due to actin and buffer alone . A standard curve for CapZ alone was constructed by varying the concentration of CapZ in the incubation between 0 and 100 nM .
To determine the effect of mAb lE5 on CapZ bound to actin filaments, 60 141 of 5.0 AM 70% pyrene-labeled actin filaments in Ca"-G-buffer was added to 60 Al of 120 nM CapZ in a silanized microfuge tube for 5 min . A sixfold molar excess of mAb IE5 to CapZ (48 Al of 900 nM in PBS) was added to 2 .4 ml Cat+-G-buffer in a fluorometer cuvette . 100 Al of the CapZ/actin filament solution was added to the cuvette, which was stirred for 15 s . In a control experiment, CapZ and mAb IE5 were added to Cat + -G-buffer in a fluorometer cuvette and preincubated for 5 min . 50 Al of 5 .0 AM pyrene actin filaments was added at t = 0 .
Recombinant Proteins. To determine the capping activity of CapZ mutants expressed as fusion proteins in bacteria, depolymerization assays were performed with the following changes . 60 Al of test solution in buffer B was added to 60 Al of 5.0 yM actin filaments and incubated for 2 min . 100 JAI was added to 2,240 Al Ca 2+-G-buffer in a fluorometer cuvette . The activity of each sample was calculated as above and divided by the value obtained for 13 .0 nM CapZ (defined as 100% capping activity) . The fractional capping activity was plotted versus the final concentration of added protein.
The concentration of recombinant protein required for 50% maximal capping activity was determined from this plot .
Nucleation Assay
The effect of antibodies on the nucleation activity of CapZ was assayed by incubating 70 Al of 1 .8 AM CapZ in buffer B with 0.1 mg/ml BSA plus 961 Al of antibody in PBS with 0.1 mg/ml BSA in silanized microfuge tubes for 1 h . 1,207 Al of 10 FM actin monomers (5% pyrene labeled) in Mgt+-Gbuffer was primed for 5 min in a fluorometer cuvette by adding 12 Al of 2 M MgC12 . At t = 0 the CapZ/antibody solution and 250 Al 10x MKEI buffer were added . The slope of the tangent at the inflection point of the plot of fluorescence versus time was calculated . To prepare a CapZ standard curve, this slope minus the slope for actin alone was plotted against the final concentration of CapZ . This standard curve was used to determine the fractional CapZ activity in samples containing varying ratios of mAb to CapZ .
Low-shear Viscometry Assay
Low-shear viscometry assays were performed with a falling-ball apparatus (18) . Actin was polymerized at high concentration, diluted to 12 AM, and added to an equal volume of test solution immediately before entry into the capillary tube . Apparent viscosities were plotted versus concentration of added test protein . The relative activity of each CapZ mutant was determined from these plots by dividing the concentration of added protein that gave a 50% maximal reduction in viscosity by the concentration of CapZ required for an equivalent reduction in viscosity.
Critical Concentration Assay
To determine the activity of COON-terminal peptides on the critical concentration of actin, 0-3.0 AM actin filaments (5 or 50% pyrene labeled), were incubated with 0-1 .5 AM purified fusion protein in Cal'-G-buffer with 104 mM KCI, 2 MM MgC12, 1 mM EGTA, 20 mM imidazole/HCI, pH 7.0 . The fluorescence was measured at 24 and 48 h. In a second experiment, 2 .0 AM actin monomers, 5% pyrene labeled, were incubated with 0-14.0 AM purified fusion protein in W'-G-buffer with 100 mM KCI, 2 MM MgC12, 1 mM EGTA, 20 mM imidazole/HCI, pH 7.0.
In Vitro Ranslation 
Results
Identification of mAb 1E5 Epitope COOH-terminal deletions of the 0 subunit of chicken CapZ were constructed using a full-length cDNA clone and two different expression vectors, pBS and pGex (Fig. 1) . Immunoblots were performed on total bacterial lysates containing the recombinant fusion proteins with mAb lE5 (Fig . 4 ) . An 
Effect ofmAb IE5 on Actin Nucleating Activity ofCapZ
Capping protein increases the rate of polymerization of monomeric actin into filaments in a manner consistent with an increase in the rate of nucleation (5, 11) . Preincubation of CapZ with mAb lE5 inhibited the nucleating activity of CapZ (Fig. 5 A) . Preincubation of CapZ with mAb 1Bll, which recognizes the a subunit ofCapZ, had no effect on the nucleating activity.
By using a standard curve relating polymerization rate to the concentration of CapZ (data not shown), we were able to quantify the extent of inhibition of CapZ with different amounts of mAb (Fig. 5 B) . 38 nM mAb IE5 led to a 50% reduction in the nucleating activity of 50 nM CapZ, indicating a Kd for binding of mAb IE5 to CapZ of -13 nM.
Effect ofmAb 1ES on Actin Filament Capping Activity ofCapZ
CapZ binds to the barbed ends of actin filaments and prevents exchange of actin monomers at this end (5, 9) . In an assay that measures the depolymerization of actin filaments after dilution, CapZ preincubated with mAb IE5 could not prevent depolymerization ofactin filaments (Fig. 6 A) . CapZ preincubated with mAb 1B11 was still capable of preventing dilution-induced depolymerization of actin filaments (data not shown) .
We also created a standard curve for CapZ activity in this assay using varied amounts of CapZ (data not shown), and related the effects of the mAbs added to the CapZ activity (Fig. 6 B) . These data indicate a 50% loss of activity when 60 nM CapZ is incubated with 36 nM mAb 1135, which predicts a Kd of N6 nM, which is in reasonably good agreement with the Kd determined by inhibition of actin filament nucleating activity. 
Effect of nL4b 1135 on CapZ Bound to Actin FTi1aments
In the previous experiment, mAb IE5 was preincubated with CapZ before the actin was added. The results show that mAb IE5 can bind CapZ and prevent it from capping actin filaments. To determine if mAb IE5 could bind to and remove CapZ that was already bound to actin filaments, we added mAb IE5 to actin filaments that had CapZ bound to their barbed ends. The filaments were diluted to determine whether they were capped . As assayed in a depolymerization assay, mAb IE5 did not inhibit CapZ bound to actin fila- All constructs are fusion proteins with GST . NA, not assayed . These results are derived from data such as those in Fig . 6 (depolymerization assays) . The low-shear viscometry data are not shown . mAb 1 E5 reactivity is derived from the immunoblots shown in Fig . 4 . ments (Fig. 7 A) . In a control experiment under the same conditions, mAb IE5 did inhibit CapZ if it was added before actin filaments (Fig. 7 B) .
Effect ofTfruncation of the COOH Terminus of CapZ ß on Activity ofExpressed Protein Recombinant a (GSTa2) and ß (GSTß(1-277)) subunits were made using the pGex expression vectors. These proteins contain GST fused to the NH2 terminus of the CapZ subunit, which permits purification by affinity chromatography . The a and ß subunits bind to each other, permitting separation ofthe heterodimer from monomer by gel filtration chromatography . The heterodimeric protein was active in a depolymerization assay and a low-shear vicometry assay (Table 11) . GST protein alone was inactive in both assays (data not shown) . On a molar basis the activity of the heterodimeric fusion protein in a depolymerization assay was 52 %, and in a low-shear viscometry assay 36% of the activity of CapZ purified from chicken muscle . In a depolymerization assay, the individual a and ß subunits had very little activity (Table II and Fig. 8 ).
Recombinant COOH-terminal truncations ofthe ß subunit made in the pGex vector (Fig. 1) were combined with GST a2 and tested for activity using the same assays . In general, activity correlated with mAb 1E5 binding (Table II) . GST a2/GSTß(1-266), which lacks 11 COOH-terminal residues and has several vector-derived residues, had a small loss of activity compared to the intact protein, GSTa2/GST ß(1-277), and was still recognized by mAb 1E5 . GST a2/GSTß(1-265), which lacks 12 COOH-terminal residues and has no vector-derived residues, had a complete loss of functional activity, as did GSTa2/GSTß(1-212), which lacks the COOH-terminal 65 residues. Neither of these two constructs were recognized by mAb 1E5. meric CapZ to actin filaments was assayed in a cosedimentation assay. Constructs that maintained mAb IE5 binding (a2/ß(1-277) and a2/ß(1-266)) cosedimented with actin filaments (Fig. 9) . A construct that was not recognized by mAb IE5 showed marked dimunition in cosedimentation with actin filaments (a2/ß(1-265), Fig . 9, pellet 5) . Addition of mAb lE5 or unlabeled CapZ inhibited cosedimentation (Fig.  9 , "+" lanes), while addition of a mAb that recognizes vinculin had no effect (data not shown) . Equal amounts of F-actin were precipitated with or without added CapZ, as determined by SDS-PAGE.
In a separate quantitative analysis, varied amounts of unlabeled muscle CapZ were added to compete for binding ofthe labeled translation products. Dixon plots showed that the Kd of a2/ß(1-266) relative to that of a2/ß(1-277) was 5.5. The binding of a2/ß(1-265) was not detectable, which implies a Kd greater than 15 times that of a2/ß(1-277) for these data.
Effect of the COOH-terminal 25 Amino Acids of the ß Subunit on the Apparent Critical Concentration ofActin
These data indicate that the COOH-terminus of CapZ 0 might be an actin-binding site. To test this hypothesis, we determined whether the COON-terminal residues of CapZ ß, prepared as a fusion protein with GST, were able to bind actin . The COOH-terminal 25 amino acids, as the fusion protein GST0(253-277), had viscosity-lowering activity in a low-shear viscometry assay. This activity was abolished by preincubation with mAb IE5 (data not shown), indicating that the structure of the peptide is similar to its structure in native CapZ. However, this fusion protein had very little activity in a depolymerization assay (Fig. 8 and Table II) .
These results indicate that GST 0(253-277) binds actin but does not cap actin filaments, suggesting that it may bind actin monomers. To test this hypothesis, we determined the (Fig . 10) . As negative controls, neither GST alone nor GST0(264-277) had any effect in this assay, which was predicted from the results in the previous sections . Similar results were obtained with 50% pyrene-labeled actin (data not shown) . In a second experiment, 21íM actin was incubated with increasing concentrations of GST0(253-277) . Complete depolymerization was observed (Fig. 11) , which indicates that GST 0(253-277) can increase the apparent critical concentration to 2 AM . This value is greater than the critical concentration for the pointed end (0.6-0.71íM [3, 5] ), which indicates that GST ß(2S3-277) does not cap barbed ends . . In a similar experiment, GST protein alone had no effect on the critical concentration (data not shown) . Actin was 5 % pyrene labeled and similar results were obtained with 50% pyrene-labeled actin (data not shown) .
The results in both experiments (Figs . 10 and 11) can be explained by GST0(253-277) binding actin monomers with a Kd of 325 nM, which is diagramed in Fig. 11 . Furthermore, the results of Fig . 10 cannot be explained by a model in which GST0(253-277) caps actin filaments with a single binding constant, and hence are not consistent with capping activity.
Discussion
Identification and Characterization ofthe Actin-binding Site mAb IE5 binds to CapZ and inhibits its ability to bind actin stoichiometrically. CapZ's ability to cap actin filaments, as measured in a depolymerization assay, and its ability to 1-265) . The inhibitor is purified muscle CapZ or mAb lE5 . In a control experiment, a mAb against vinculin had no effect (data not shown) . nucleate actin polymerization from monomers are both inhibited. mAb IE5 does not bind to CapZ that is bound to an actin filament and remove it from the filament. These results indicate that the binding of mAb IE5 and actin to CapZ are mutually exclusive, perhaps because the binding sites are overlapping or identical . To test this idea, we located the binding site of mAb IE5 and then determined whether that region of CapZ was important for binding actin.
Epitope mapping shows that mAb IE5 binds near the COOH terminus of CapZ 0 . Loss of the terminal 12 residues leads to loss of binding. In a construct in which several vector-derived residues are substituted in place ofthe terminal 11 residues, binding is preserved, implying that the structure of the epitope is restored by these residues. The 000H-terminal25 residues are sufficient for binding of mAb lE5, and the COOH-terminal 14 residues are not. Together these results indicate the COOH-terminal 25 residues are necessary and sufficient for antibody binding .
Deletion of the COOH-terminal 12 residues of the 0 subunit in recombinant expressed CapZ also leads to a loss of ability to cap actin filaments. In these experiments, both a and 0 subunits were required for full activity. When both complete subunits were expressed separately as fusion proteins and combined into heterodimers, the product was capable of capping actin filaments, although at a level quantitatively less than that of'purified muscle CapZ . Truncation of the'COOH terminus of CapZ 0 such that mAb IE5 did not bind led to a nearly complete loss of activity. In an in vitro translation system that expresses CapZ with no fusion protein, the expressed heterodimer bound actin filaments with high affinity. Truncation ofthe COOH-terminal region again led to a total loss of actin binding activity. Taken To distinguish between these alternatives, we tested whether the COOH-terminal region could bind actin on its own . We prepared a peptide corresponding to the 000H-terminal25 amino acids of CapZ 0 as a fusion protein. This protein binds actin monomers based on determinations of its effect on the apparent critical concentration of actin. Incubation of this fusion protein with mAb IE5 inhibited its activity in a low-shear viscometry assay, indicating that the actinbinding properties of the peptide are due to the same structure as in the native protein. A fusion protein that included the COON-terminal 14 amino acids had no effect in the critical concentration assay or the low-shear viscometry assay.
Implications for the Mechanism of CapZ Binding to Actin *e want to emphasize that the COOH-terminal 25 amino acids, as a fusion protein, does not cap actin filaments as does CapZ, and that unlike CapZ, the fusion protein is capable of binding actin monomers. The peptide clearly does not replicate the interaction of CapZ with actin. We envision two alternative implications ofthis discrepancy : CapZ has one or more actin-binding sites. First, ifCapZ has one actin-binding site, then the peptide may encompass part but not all of the The Joumal of Cell Biology, Volume 116, 1992 actin-binding region . Indeed, the affinity of the peptide for actin monomers is low (Kd = 325 nM) compared to that of CapZ for barbed ends of filaments (Kd = 1 nM [5] ) . On the other hand, if CapZ has more than one actin-binding site, the COOH terminus of the 0 subunit may represent one of these sites . In this case, the combination of more than one lowaffinity actin monomer-binding site could yield a single highaffinity actin filament-binding site.
An argument against the multiple-site model is that the heterodimer lacking the COOH-terminal 12 amino acids of CapZ 0 (a2/ß(1-265)) does not bind actin in these experiments. No activity was detectable in the functional assay (low-shear viscometry), whereas the COOH-terminal 25 amino acids has some activity in this assay (Table II) .
However, ifthe binding at a second site did not prevent actin polymerization, this would not have been detected in the low-shear viscometry assay. Physical binding should not depend on this function . Cosedimentation with filaments was also undetectable, although the limits of detection of this assay were 15-fold, which is not sensitive to exclude a 300-fold difference in binding constants such as is seen between the COOH-terminal region (GSTß (2S3-277) ) and native CapZ.
Primary Sequence ofthe Actin-binding Site The primary sequence of the actin-binding site has two interesting features . First, this sequence is not conserved across species. In general, the 0 subunit is highly conserved, with 50 % identity between yeast and other species, including chicken, Dictyostelium discoideum, and Caenorhabditis elegans (1, Waddle, J. A., J. A . Cooper, and R. H . Waterston, unpublished results, 1991) . However, no similarity is found among the species in the COOH-terminal region of the 0 subunit . Therefore, the conventional notion that functionally important residues are conserved through evolution may not hold in this case, or, as noted above, this region may represent a portion of the actin-binding site and additional conserved residues may be involved .
Second, this site is not similar to actin-binding sites of other actin-binding proteins, implying that it represents a novel class of actin-binding sites . We noted previously that the primary sequences of capping protein alpha and beta are not similar to those of any other protein (6, 11) . We have now compared the primary sequence of the COOH-terminal region of the 0 subunit to the database and to conserved regions of actin-binding proteins that may represent actinbinding sites and find no significant similarity. In this analysis we used the actin-binding site of cofilin (27) , which is similar to regions of thymosin 04 (20) and actobindin (26) , and we used regions of similarity identified (24) in actin, the gelsolin family, profilin, and DNase I.
One possible feature of similarity may be positive charge . Basic residues are a prominent feature of the cofilin/thymosin04/actobindin sequences . Capping protein 0 does include an arginine in the COON-terminal region in approximately the same position in all four species. In addition, truncation of CapZ 0 from 277 to 265 residues leads to a loss ofactivity, but the activity can be partially restored by a different construct (0 of Fig . 1 and Table II) in which several vector-derived residues, including an arginine and a histidine, follow 0266.
